Awareness Of Thalassemia In Male And Female Students
DOI:
https://doi.org/10.46966/msjar.v3i4.92Keywords:
Thalassaemia, Haemoglobinopathy, AwarenessAbstract
Objective:-Objective of this look at is to access the awareness stage of Thalassaemia in University college students. Method: Study design was chosen to be crosssectional prospective. Sample size for this study was taken as 64. . A wellstructured:data collecting form or questionnaire was created, analysedand filled out during the interview.The data was summarized using descriptive statistics. Results The total 64 cases of all age groups were enrolled in this study. The are 64 cases of all age group are involved in this study in which there are 21 male (32.8%) and 43 females (67.2%). In this survey out of 64 persons 53 persons know about thalassemia. 5 people know about thalassemia gene. 40 persons know that thalassemia is inherited from parents. 53 persons know that thalassemia is blood related disease. 45 persons know severe anaemia is the clinical presentation of thalassemia. 25 persons know about the permanent treatment of thalassemia. 37 persons know that thalassemia is treated by bone marrowtransplantation.However, the study findings revealed that education status had a substantial impact.
Conclusion:- Females have more awareness about thalassemia then man.
References
Galanello R and Origa R. Beta-Thalassemia Orphanet. Journal of Rare Diseases 2010; 5(11):1172-75.
Delea TE, Edelsberg J, Sofrygin O, Thomas SK, BaladiJF,et al. (2007) Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review. Transfusion 47(10): 1919-1929.
Ahmed S, Saleem M, Modell B, Petrou M (2002) Screening extended families for genetic hemoglobin disorders in Pakistan. New England Journal of medicine 347(15): 1162-1168.
Muncie HL, Campbell JS (2009) Alpha and beta thalassemia. American family physician 80(4): 339-344.2. Cao A, Kan YW (2013) The prevention of thalassemia. Cold Spring Harbor perspectives in medicine 3(2): a011775.
lDelea TE, Edelsberg J, Sofrygin O, Thomas SK, BaladiJF,et al. (2007) Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review. Transfusion 47(10): 1919-1929.
AhmedS, SaleemM,Modell B, Petrou M (2002) Screeningextended families for genetic hemoglobin disorders in Pakistan. New England Journal of medicine 347(15): 1162-1168.
Shang X, Xu X (2017) Update in the genetics of thalassemia: What clinicians need to know. Best Practice & Research Clinical Obstetrics & Gynaecology 39: 3-15.
Baig SM, Azhar A, Hassan H, Baig JM, Aslam M, et al. (2006) Prenatal diagnosis of β‐ thalassemia in Southern Punjab, Pakistan. Prenatal diagnosis 26(10): 903-905.
BorgnaPignatti C, Rugolotto S, Stefano PF, Zhao H, Cappellini MD, et al. (2004) Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89(10):1187-1193.
Borgna-Pignatti C, Rugolotto S, De Stefano P, Piga A, Di Gregorio F, et al. (1998) Survival and disease complications in thalassemia major. Ann N Y AcadSci 850(1): 227-231.
Haddad A. β-Thalassemia Intermedia: A Bird's-Eye View. Turkish Journal of Hematology, 2014, 31(1).
Maheen H. Assessing Parental Knowledge aboutThalassemia in a Thalassemia Center of Karachi, Pakistan. Journal of genetic counseling.
Feinstein L. 4. What are the effects of education on health? In measuring the effects of education on health and civic engagement
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Rimsha Qayyum
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
